Zurich, Switzerland

Mireia Sospedra Ramos

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Unversität Zürich. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mireia Sospedra Ramos. Retrieved from https://idiyas.com/inventor/mireia-sospedra-ramos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mireia Sospedra Ramos: Innovator in Multiple Sclerosis Research

Introduction

Mireia Sospedra Ramos is a notable inventor based in Zürich, Switzerland. She is affiliated with the Universität Zürich, where she contributes to research in the field of immunology. Although she currently holds no granted patents, her work is focused on significant advancements in the treatment and understanding of multiple sclerosis.

Latest Patent Applications

Mireia's latest patent applications include "Immunodominant Proteins and Fragments in Multiple Sclerosis." This disclosure relates to the treatment, diagnosis, and prevention of multiple sclerosis (MS) by utilizing an immunodominant protein or peptide. More specifically, the invention pertains to the field of antigen-specific immunotherapies, such as the induction of tolerance. This application highlights her commitment to developing innovative solutions for complex medical challenges.

Conclusion

Mireia Sospedra Ramos is an emerging figure in the realm of medical research, particularly in the area of multiple sclerosis. Her ongoing work and patent applications reflect her dedication to advancing healthcare through innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…